Drug Delivery System in the Optimization of Ultrasound-Activated Nanoparticles and Magnetic Fields for Precise Drug Release in Parkinson's Disease Treatment

This article presents a comprehensive analysis of hybrid nanoparticles activated by ultrasound and magnetic fields as innovative systems for drug delivery in the treatment of Parkinson's disease. These systems combine precision, control, and efficacy, offering promising solutions for personalized medicine. The article reviews the current state of these technologies, highlighting their evolution from basic concepts in physics and biochemistry to potential clinical applications. The potential of ultrasound for precise tissue penetration and the spatial control offered by magnetic fields are discussed, alongside the challenges of optimizing technical parameters, ensuring long-term safety, and scaling up for clinical use. Key Areas Covered: The development of hybrid nanoparticles combining magnetic and ultrasound stimuli for controlled drug release. Advances in personalized medicine through targeted delivery to specific brain regions. The challenges of clinical applicability, including safety, toxicity, and regulatory issues. Opportunities for integrating these systems with other therapies, such as gene therapy and neuroprotection. Future research needs to address long-term efficacy, bioaccumulation, and personalized treatment protocols. This article serves as a critical review of existing literature, outlining both the current capabilities and gaps in research, and providing valuable insights into the future of nanoparticle-based drug delivery systems for neurodegenerative diseases like Parkinson's.